Journal of Antimicrobial Chemotherapy (2000) 46, 685-693
© 2000 The British Society for Antimicrobial Chemotherapy
In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride
a Laboratoire de virologie, Hôpital Broussais, Paris, France; b Unité INSERM U430 and Université Pierre et Marie Curie (Paris VI), Hôpital Broussais; c Institut Alfred Fournier, Paris, France
Kinetics of inactivation by the detergent spermicide benzalkonium chloride (BZK) of Chlamydia trachomatis and of a panel of DNA viruses [herpes simplex virus hominis type 2 (HSV-2), cytomegalovirus (CMV), adenovirus (ADV) and BK virus (BKV)] and RNA [respiratory syncytial virus (RSV) and enterovirus (ENV)] were established in accordance with a standardized in vitro protocol. After a 5 min incubation, inactivation of >95% of HSV-2 and CMV was obtained at a concentration of 0.0025% (w/v) (25 Ìg/L); concentrations as low as 0.0005%, 0.0050% and 0.0125%, induced a 3.0 log10 reduction in infectivity of HSV-2 and CMV, RSV and ADV, respectively. After a 60 min incubation, concentrations of 0.0125% and 0.050% provided a 3.0 log10 reduction in infectivity of ENV and BKV, respectively. These features indicate that sensitivity to BZK was very high (HSV-2 and CMV) or high (RSV) for enveloped viruses, intermediate (ADV) or low (ENV and BKV) for non-enveloped viruses. Furthermore, BZK had marked antichlamydial activity, showing >99% killing after only a 1 min incubation at a concentration of 0.00125%. BZK demonstrates potent in vitro activity against the majority of microorganisms causing sexually transmitted infectious diseases, including those acting as major genital cofactors of human immunodeficiency virus transmission. These attributes qualify BZK as a particularly attractive candidate for microbicide development.
* Correspondence address. Unité INSERM U430, Hôpital Broussais, 96 rue Didot, 75674 Paris Cedex 14, France. Fax: + 33-1-45-45-90-59; E-mail: laurent.belec{at}brs.ap-hop-paris.fr
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Yamazaki, T. Kishimoto, S. Shiga, K. Sato, T. Hagiwara, M. Inoue, N. Sasaki, K. Ouchi, and Y. Hara Biosynthesized Tea Polyphenols Inactivate Chlamydia trachomatis In Vitro Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2501 - 2503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamano, T. Yamazaki, K. Sato, S. Shiga, T. Hagiwara, K. Ouchi, and T. Kishimoto In Vitro Inhibitory Effects of Hinokitiol on Proliferation of Chlamydia trachomatis Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2519 - 2521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Lampe, L. C. Rohan, M. C. Skinner, and W. E. Stamm Susceptibility of Chlamydia trachomatis to Excipients Commonly Used in Topical Microbicide Formulations Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3200 - 3202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Taylor-Robinson and R. C. Ballard In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride J. Antimicrob. Chemother., May 1, 2001; 47(5): 721 - 722. [Full Text] [PDF]
|
|